Zhuhai United Bio-Pharmaceutical Co., Ltd.

Zhuhai United Bio-Pharmaceutical Co., Ltd., founded in 2021 and located in Sanzao Town, Jinwan District, Zhuhai, originated from the Biological Research Institute of Zhuhai United Laboratories Co., Ltd., which was founded in 2002. The company, which covers an area of over 90,000 square meters with more than 700 employees, is an innovative pharmaceutical enterprise focused on the integrated development, optimization, production, sales, and technical services of biopharmaceuticals, animal healthcare products, and pharmaceutical excipients, serving as a high-tech platform and production entity for the transformation of achievements in the biopharmaceutical, animal healthcare, and pharmaceutical excipient sectors of United Laboratories. The company has established mature platforms for strain preservation, fermentation process optimization, R&D of pharmaceutical intermediates, purification process optimization, quality research, formulation studies, and polypeptide drug technology development. With a focus on the R&D of pharmaceutical products targeting energy metabolism, inflammation, and autoimmune diseases, the company’s primary task is to research and develop high-end biopharmaceuticals to treat major chronic diseases. It has successfully developed and launched a series of biological products, including human insulin, insulin glargine, and insulin aspart, and has established a leading domestic diabetes biopharmaceutical development pipeline, and its polypeptide product R&D platform has successfully developed multiple projects.